NCT04685148View on ClinicalTrials.gov

Maternal Mental Health Trial

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2030

Conditions
Major Depressive DisorderPostpartum Depression
Interventions
DRUG

Transdermal patch estradiol

Estradiol patches (200 μg per day by transdermal delivery) will be administered at day 0 (+1) to day 21 postpartum.

DRUG

Transdermal patch placebo

Placebo patches will be administered at day 0 (+1) to day 21 postpartum.

Trial Locations (1)

2100

RECRUITING

Neurobiology Researc hUnit, Copenhagen

All Listed Sponsors
collaborator

Herlev Hospital

OTHER

collaborator

Hvidovre University Hospital

OTHER

lead

Vibe G Frøkjær, MD, PhD

OTHER